贝叶斯网络对随机对照试验的元分析,比较胆固醇调节剂在精神分裂症中的疗效和安全性
Amiya Shaju1, Archana Mishra1, Biswa Ranjan Mishra2
1Department of Pharmacology, All India Institute of Medical Sciences (AIIMS), Bhubaneswar, India.
Journal of psychopharmacology (Oxford, England)
|December 1, 2025
概括
这一网络元分析发现,肌肉激素和尼古丁激素激剂显著降低精神分裂症症状,肌肉激素激素显示出最高的疗效. 特洛皮塞特朗和沙诺梅林特别有效,为现有治疗提供了有前途的替代方案.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胆固醇系统调节多巴胺,在精神分裂症治疗中显示出治疗潜力.
- 克萨诺米林 (M1 / M4激动剂) 与托斯皮安是FDA批准的;其他M4和尼古丁调节剂正在出现.
- 之前没有网络元分析 (NMA) 对这些药物进行过精神分裂症的评估.
研究的目的:
- 进行贝叶斯网络元分析 (NMA),比较胆固醇调节剂在精神分裂症中的疗效和安全性.
- 为了评估这些药物对阳性和阴性综合征尺度 (PANSS) 总得分和子尺度的影响.
主要方法:
- 按照PRISMA-NMA指南进行了随机对照试验 (RCT) 的贝叶斯式NMA.
- 数据来源于主要的数据库 (MEDLINE,Embase,科学网络,Cochrane,ICTRP).这些数据来源于主要的数据库.
- 主要结局:PANSS总分数的变化;次要结局:PANSS分级,负症状,CGI-S和不良事件.
主要成果:
- 30个RCT (3128名参与者) 评估了14项干预措施与安慰剂对比.
- 肌肉激动剂 (SMD: -0.61) 和尼古丁激动剂 (SMD: -0.26) 显著降低了PANSS总得分.
- 肌肉激动剂在疗效方面排名最高 (SUCRA:95.41%);Tropisetron和xanomeline显示出显著的疗效,但在不良事件中没有显著差异.
结论:
- 与安慰剂相比,托皮塞特朗和沙诺梅林在减少精神分裂症症状方面表现出更高的疗效.
- 这些药物代表了与传统抗精神病药物具有相似安全性概况的有希望的替代品.
- 建议进行进一步的研究,包括RCT和NMA,以验证这些发现并为临床实践提供信息.
相关概念视频
Indirect-Acting Cholinergic Agonists: Pharmacological Actions
1.4K
Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
1.4K
Alzheimer's Disease: Treatment
764
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
764
Direct-Acting Cholinergic Agonists: Pharmacokinetics
1.8K
Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
1.8K
Cholinergic Antagonists: Pharmacological Actions
1.6K
Antimuscarinic drugs block muscarinic receptors in multiple systems, including the gut, eye, smooth muscles, respiratory tract, cardiovascular, and central nervous systems. They produce similar effects with varying selectivity depending on the specific agent and tissue. Here are the key pharmacological actions of antimuscarinics:
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
Gastrointestinal Effects: Antimuscarinics reduce gut contractions, increase gastric emptying, and slow intestinal transit. They partly inhibit gastric acid secretion...
1.6K
Direct-Acting Cholinergic Agonists: Pharmacological Actions
2.2K
Direct-acting cholinergic agonists exert their pharmacological actions by mimicking the effects of acetylcholine on postsynaptic muscarinic receptors to generate parasympathetic responses. These agents elicit a range of physiological responses, including cardiovascular effects. For example, activation of muscarinic receptors induces bradycardia, decreased cardiac output, reduced peripheral resistance, and consequent hypotension. In the eye, stimulation of M3 receptors leads to smooth muscle...
2.2K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
1.5K
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
1.5K


